GlassScriptPhysician profile
David Ching-Wei Lee
NPI 1427652304
$3,986.66
in general payments reported to CMS, 2019-2025
12 companies · $823 in 2025
The $823 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,605 · 2022: $401 · 2023: $437 · 2024: $721 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Travel and Lodging: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.19 |
| Travel and Lodging | $588.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,315.04 | 2021 | |
| Stryker Corporation | $858.12 | 2022-2025 | Gamma, Pangea, Allograft |
| Medacta USA, INC. | $630.40 | 2022-2025 | Gmk Sphere, Amistem |
| Zimmer Biomet Holdings, INC. | $289.97 | 2021 | |
| Bioventus LLC | $255.29 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Orthalign INC | $236.67 | 2024 | Orthalign Plus |
| Globus Medical, INC. | $188.26 | 2022-2025 | Autobahn |
| Saxum Surgical, INC. | $93.92 | 2024 | |
| Smith+Nephew, INC. | $39.70 | 2023 | Renasys Go V2 Home, Pico 7 |
| Linvatec Corporation | $31.34 | 2024 | Linvatec Shoulder Arthroscopy, Biobrace 23mm, Linvatec Arthroscopy |
| Fidia Pharma USA INC. | $29.75 | 2023 | Triluron, Hymovis |
| Mimedx Group, INC. | $18.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.